Photocure ASAPhotocure ASAPhotocure ASA

Photocure ASA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪120.72 M‬USD
0.05USD
‪96.11 K‬USD
‪49.15 M‬USD
‪23.65 M‬
Beta (1Y)
0.29
Employees (FY)
102
Change (1Y)
−4 −3.77%
Revenue / Employee (1Y)
‪481.88 K‬USD
Net income / Employee (1Y)
942.29USD

About PHOTOCURE ASA


CEO
Daniel Schneider
Headquarters
Oslo
Founded
1993
ISIN
NO0010000045
FIGI
BBG000CM3WS3
Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. Its products include Metvix for nonmelanoma skin cancer, Hexvix/Cysview for better detection and management of bladder cancer, and Cevira which is a photodynamic drug-device combination product for non-surgical treatment of high-grade cervical dysplasia. The company operates through the Commercial Franchise and Development Portfolio segments. The Commercial Franchise segment includes the sale of Hexvix/Cysview in the U.S. and Europe and other sales from partners and other products. The Development Portfolio segment focuses on the development of pipeline products. The company was founded in 1997 and is headquartered in Oslo, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PHCUF is 4.48 USD — it has decreased by −6.67% in the past 24 hours. Watch Photocure ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Photocure ASA stocks are traded under the ticker PHCUF.
PHCUF stock hasn't changed in a week, the last month showed zero change in price, over the last year Photocure ASA has showed a −4.88% decrease.
We've gathered analysts' opinions on Photocure ASA future price: according to them, PHCUF price has a max estimate of 7.63 USD and a min estimate of 7.54 USD. Watch PHCUF chart and read a more detailed Photocure ASA stock forecast: see what analysts think of Photocure ASA and suggest that you do with its stocks.
PHCUF reached its all-time high on Jun 15, 2021 with the price of 17.57 USD, and its all-time low was 2.70 USD and was reached on Dec 11, 2014. View more price dynamics on PHCUF chart.
See other stocks reaching their highest and lowest prices.
PHCUF stock is 7.14% volatile and has beta coefficient of 0.29. Track Photocure ASA stock price on the chart and check out the list of the most volatile stocks — is Photocure ASA there?
Today Photocure ASA has the market capitalization of ‪120.72 M‬, it has decreased by −2.54% over the last week.
Yes, you can track Photocure ASA financials in yearly and quarterly reports right on TradingView.
Photocure ASA is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
PHCUF earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.02 USD resulting in a 46.90% surprise. The estimated earnings for the next quarter are 0.02 USD per share. See more details about Photocure ASA earnings.
Photocure ASA revenue for the last quarter amounts to ‪11.35 M‬ USD, despite the estimated figure of ‪11.11 M‬ USD. In the next quarter, revenue is expected to reach ‪11.77 M‬ USD.
PHCUF net income for the last quarter is ‪−327.62 K‬ USD, while the quarter before that showed ‪1.15 M‬ USD of net income which accounts for −128.39% change. Track more Photocure ASA financial stats to get the full picture.
No, PHCUF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 1, 2024, the company has 102.00 employees. See our rating of the largest employees — is Photocure ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Photocure ASA EBITDA is ‪15.24 M‬ USD, and current EBITDA margin is 30.48%. See more stats in Photocure ASA financial statements.
Like other stocks, PHCUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Photocure ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Photocure ASA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Photocure ASA stock shows the sell signal. See more of Photocure ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.